Heart failure with preserved ejection fraction in the elderly: scope of the problem

Journal of Molecular and Cellular Cardiology
Bharathi UpadhyaDalane W Kitzman

Abstract

Heart failure with preserved ejection fraction (HFpEF) is the most common form of heart failure (HF) in older adults, particularly women, and is increasing in prevalence as the population ages. With morbidity and mortality on par with HF with reduced ejection fraction, it remains a most challenging clinical syndrome for the practicing clinician and basic research scientist. Originally considered to be predominantly caused by diastolic dysfunction, more recent insights indicate that HFpEF in older persons is typified by a broad range of cardiac and non-cardiac abnormalities and reduced reserve capacity in multiple organ systems. The globally reduced reserve capacity is driven by: 1) inherent age-related changes; 2) multiple, concomitant co-morbidities; 3) HFpEF itself, which is likely a systemic disorder. These insights help explain why: 1) co-morbidities are among the strongest predictors of outcomes; 2) approximately 50% of clinical events in HFpEF patients are non-cardiovascular; 3) clinical drug trials in HFpEF have been negative on their primary outcomes. Embracing HFpEF as a true geriatric syndrome, with complex, multi-factorial pathophysiology and clinical heterogeneity could provide new mechanistic insights and opportuni...Continue Reading

References

Feb 1, 1986·Circulation Research·M B HigginbothamF R Cobb
Oct 1, 1995·Journal of the American College of Cardiology·G OlivettiP Anversa
Aug 1, 1994·British Heart Journal·A J CoatsP A Poole-Wilson
Mar 1, 1993·Cardiovascular Research·K T WeberJ S Janicki
Dec 31, 1997·Journal of the American College of Cardiology·D HarringtonA J Coats
Oct 28, 1999·The New England Journal of Medicine·C R ColeM S Lauer
May 12, 2000·Journal of the American College of Cardiology·J S GottdienerR C Boineau
Mar 9, 2002·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·F M E FranssenA M W J Schols
Mar 30, 2002·Journal of the American College of Cardiology·Brian D DuschaWilliam E Kraus
Nov 7, 2002·JAMA : the Journal of the American Medical Association·Dalane W KitzmanKathryn P Stewart
Jan 13, 2004·Journal of Cardiovascular Pharmacology·William C LittleChe-Ping Cheng
Mar 17, 2004·Physiological Genomics·Anna CsiszarGabor Kaley
May 7, 2004·The New England Journal of Medicine·Michael R ZileWilliam H Gaasch
May 28, 2004·Nature·Aleksandra TrifunovicNils-Göran Larsson
Apr 12, 2005·Cardiovascular Research·David Kaye, Murray Esler
Aug 5, 2005·Science of Aging Knowledge Environment : SAGE KE·Linda P FriedLuigi Ferrucci
Sep 6, 2005·Science·Phillip D Zamore, Benjamin Haley
Sep 22, 2005·Clinical and Experimental Pharmacology & Physiology·Jennifer MartinHenry Krum
Oct 6, 2005·Circulation·Margaret M RedfieldDavid A Kass
Jan 13, 2006·Archives of Internal Medicine·Lawrence LiaoJohn S Gottdiener
Jan 20, 2006·Muscle & Nerve·Merrill D BensonKyle W Sloop
Feb 4, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Leanne GrobanWilliam E Sonntag
Mar 28, 2006·Nature·Tracy S ZimmermannIan MacLachlan

❮ Previous
Next ❯

Citations

Oct 17, 2015·Journal of the American Society of Hypertension : JASH·Friedrich C Luft
Apr 15, 2015·Journal of Molecular and Cellular Cardiology·Edward G Lakatta
May 9, 2015·Journal of Cardiac Failure·James C FangUNKNOWN Heart Failure Society of America Guidelines Committee
Jul 15, 2015·Radiation Oncology·Tanja SkyttäPirkko-Liisa Kellokumpu-Lehtinen
May 28, 2015·Age·Christian HeissUNKNOWN FLAVIOLA Consortium, European Union 7th Framework Program
May 25, 2016·The American Journal of Medicine·Parag GoyalLuke K Kim
Aug 4, 2016·Methodist DeBakey Cardiovascular Journal·Anisha A Gupte, Dale J Hamilton
Oct 30, 2015·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Guillermo MedranoGeorge E Taffet
Jul 28, 2016·Age·Beatriz Martín-Fernández, Ricardo Gredilla
Oct 23, 2016·Journal of Cardiac Failure·David W Schopfer, Daniel E Forman
Mar 24, 2016·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Allan K AlencarLeanne Groban
Mar 8, 2017·Aging Cell·Lavanya BellumkondaDaniel R Goldstein
Apr 7, 2017·Circulation Journal : Official Journal of the Japanese Circulation Society·Eisaku HaradaHirofumi Yasue
Mar 16, 2017·The Journal of Physiology·Kazuki HottaJudy M Muller-Delp
Mar 15, 2018·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Katarzyna A CieslikGeorge E Taffet
Aug 23, 2018·Journal of Cellular Physiology·Xiaochen HeJian-Xiong Chen
Dec 6, 2017·Current Opinion in Cardiology·George A HeckmanKenneth Rockwood
Jan 17, 2019·Acta Cardiologica·Ruxandra-Nicoleta HorodinschiCamelia Cristina Diaconu
Mar 5, 2019·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Ian Warbrick, Simon W Rabkin
Apr 2, 2019·The Journal of Nutrition, Health & Aging·J WooE Fung
Jul 2, 2019·Journal of the American Geriatrics Society·Kenichi MatsushitaMorimasa Takayama
Dec 21, 2019·Journal of the American Geriatrics Society·Kenichi MatsushitaMorimasa Takayama
Aug 20, 2019·Journal of Cardiovascular Pharmacology·Heng Zeng, Jian-Xiong Chen
Jul 21, 2020·ESC Heart Failure·Josephine KermerJeanette Schulz-Menger
Mar 21, 2018·Frontiers in Cardiovascular Medicine·Raffaele AltaraGeorge W Booz
Jun 16, 2018·American Journal of Physiology. Heart and Circulatory Physiology·JoAnn Trial, Katarzyna A Cieslik
Mar 16, 2019·Frontiers in Cardiovascular Medicine·Heng Zeng, Jian-Xiong Chen
Jul 25, 2019·Frontiers in Physiology·Izabella UchmanowiczEwa A Jankowska
Apr 30, 2020·The Journal of Nutrition, Health & Aging·X YangE Fung
Aug 22, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Lydia E MatesicFrancis G Spinale
Jul 11, 2018·Clinical Science·Vanessa Obas, Ramachandran S Vasan
Jan 30, 2020·Frontiers in Endocrinology·Leanne GrobanSarah H Lindsey
Oct 11, 2017·Cardiovascular Research·Filippo PerbelliniCesare M Terracciano
Aug 5, 2017·Frontiers in Endocrinology·Raffaele AltaraGeorge W Booz
May 1, 2019·Journal of Cardiovascular Development and Disease·Jennifer L RodgersSiva K Panguluri
Jul 1, 2016·European Heart Journal. Quality of Care & Clinical Outcomes·John E Sanderson
Apr 3, 2018·The Journal of Clinical Investigation·Bennett G ChildsJan M van Deursen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Aging

This feed focuses on cellular aging with emphasis on mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiac Amyloidosis

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Discover the latest research on cardiac amyloidosis here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Related Papers

Expert Opinion on Medical Diagnostics
Peter Moritz BecherDirk Westermann
Drugs & Aging
Kannayiram AlagiakrishnanWilbert S Aronow
Current Cardiovascular Risk Reports
Scott L Hummel, Dalane W Kitzman
Journal of Geriatric Cardiology : JGC
Marzia Rigolli, Gillian A Whalley
© 2022 Meta ULC. All rights reserved